Eastern 0 7 0 7 B-clinical_variable
Cooperative 8 19 8 19 I-clinical_variable
Oncology 20 28 20 28 I-clinical_variable
Group 29 34 29 34 I-clinical_variable
performance 35 46 35 46 I-clinical_variable
status 47 53 47 53 I-clinical_variable
of 54 56 54 56 O
0 57 58 57 58 B-lower_bound
or 59 61 59 61 O
1 62 63 62 63 B-upper_bound

For 0 3 64 67 O
men 4 7 68 71 B-gender
and 8 11 72 75 O
women 12 17 76 81 B-gender
of 18 20 82 84 O
child 21 26 85 90 O
bearing 27 34 91 98 O
potential 35 44 99 108 O
: 44 45 108 109 O
agreement 46 55 110 119 B-contraception_consent
to 56 58 120 122 I-contraception_consent
remain 59 65 123 129 I-contraception_consent
abstinent 66 75 130 139 I-contraception_consent
or 76 78 140 142 I-contraception_consent
use 79 82 143 146 I-contraception_consent
protocol 83 91 147 155 I-contraception_consent
defined 92 99 156 163 I-contraception_consent
contraceptive 100 113 164 177 I-contraception_consent
measures 114 122 178 186 I-contraception_consent
during 123 129 187 193 O
the 130 133 194 197 O
treatment 134 143 198 207 B-treatment
period 144 150 208 214 O
and 151 154 215 218 O
for 155 158 219 222 O
at 159 161 223 225 O
least 162 167 226 231 O
5 168 169 232 233 B-lower_bound
months 170 176 234 240 I-lower_bound
after 177 182 241 246 O
the 183 186 247 250 O
last 187 191 251 255 O
dose 192 196 256 260 O
of 197 199 261 263 O
atezolizumab 200 212 264 276 B-treatment
/ 212 213 276 277 O
placebo 213 220 277 284 B-treatment
, 220 221 284 285 O
or 222 224 286 288 O
for 225 228 289 292 O
at 229 231 293 295 O
least 232 237 296 301 O
6 238 239 302 303 B-lower_bound
months 240 246 304 310 I-lower_bound
after 247 252 311 316 O
the 253 256 317 320 O
last 257 261 321 325 O
dose 262 266 326 330 O
of 267 269 331 333 O
paclitaxel 270 280 334 344 B-treatment

Known 0 5 345 350 O
central 6 13 351 358 B-chronic_disease
nervous 14 21 359 366 I-chronic_disease
system 22 28 367 373 I-chronic_disease
( 29 30 374 375 I-chronic_disease
CNS 30 33 375 378 I-chronic_disease
) 33 34 378 379 I-chronic_disease
disease 35 42 380 387 I-chronic_disease

Leptomeningeal 0 14 388 402 B-cancer
disease 15 22 403 410 O

Major 0 5 411 416 B-treatment
surgical 6 14 417 425 I-treatment
procedure 15 24 426 435 I-treatment
within 25 31 436 442 O
4 32 33 443 444 B-upper_bound
weeks 34 39 445 450 I-upper_bound
prior 40 45 451 456 I-upper_bound
to 46 48 457 459 O
randomization 49 62 460 473 O
or 63 65 474 476 O
anticipation 66 78 477 489 O
of 79 81 490 492 O
the 82 85 493 496 O
need 86 90 497 501 O
for 91 94 502 505 O
a 95 96 506 507 O
major 97 102 508 513 B-treatment
surgical 103 111 514 522 I-treatment
procedure 112 121 523 532 I-treatment
during 122 128 533 539 O
the 129 132 540 543 O
study 133 138 544 549 O
other 139 144 550 555 O
than 145 149 556 560 O
for 150 153 561 564 O
diagnosis 154 163 565 574 O

Malignancies 0 12 575 587 B-cancer
other 13 18 588 593 O
than 19 23 594 598 O
TNBC 24 28 599 603 B-cancer
within 29 35 604 610 O
5 36 37 611 612 B-upper_bound
years 38 43 613 618 I-upper_bound
prior 44 49 619 624 I-upper_bound
to 50 52 625 627 O
randomization 53 66 628 641 O

Negative 0 8 642 650 O
hepatitis 9 18 651 660 B-chronic_disease
C 19 20 661 662 I-chronic_disease
virus 21 26 663 668 I-chronic_disease
( 27 28 669 670 I-chronic_disease
HCV 28 31 670 673 I-chronic_disease
) 31 32 673 674 I-chronic_disease
antibody 33 41 675 683 O
test 42 46 684 688 O
at 47 49 689 691 O
screening 50 59 692 701 O

Negative 0 8 702 710 O
human 9 14 711 716 B-chronic_disease
immunodeficiency 15 31 717 733 I-chronic_disease
virus 32 37 734 739 I-chronic_disease
( 38 39 740 741 I-chronic_disease
HIV 39 42 741 744 I-chronic_disease
) 42 43 744 745 I-chronic_disease
test 44 48 746 750 O
at 49 51 751 753 O
screening 52 61 754 763 O

Participants 0 12 764 776 O
with 13 17 777 781 O
locally 18 25 782 789 O
advanced 26 34 790 798 O
or 35 37 799 801 O
metastatic 38 48 802 812 O
, 48 49 812 813 O
histologically 50 64 814 828 O
documented 65 75 829 839 O
TNBC 76 80 840 844 B-cancer
( 81 82 845 846 O
absence 82 89 846 853 O
of 90 92 854 856 O
human 93 98 857 862 O
epidermal 99 108 863 872 O
growth 109 115 873 879 O
factor 116 122 880 886 O
receptor 123 131 887 895 O
2 132 133 896 897 O
[ 134 135 898 899 O
HER2 135 139 899 903 O
] 139 140 903 904 O
, 140 141 904 905 O
estrogen 142 150 906 914 O
receptor 151 159 915 923 O
[ 160 161 924 925 O
ER 161 163 925 927 O
] 163 164 927 928 O

Spinal 0 6 929 935 B-chronic_disease
cord 7 11 936 940 I-chronic_disease
compression 12 23 941 952 I-chronic_disease
not 24 27 953 956 O
definitively 28 40 957 969 O
treated 41 48 970 977 O
with 49 53 978 982 O
surgery 54 61 983 990 B-treatment
and/or 62 68 991 997 O
radiation 69 78 998 1007 B-treatment

The 0 3 1008 1011 O
HBV 4 7 1012 1015 B-chronic_disease
DNA 8 11 1016 1019 O
test 12 16 1020 1024 O
will 17 21 1025 1029 O
be 22 24 1030 1032 O
performed 25 34 1033 1042 O
only 35 39 1043 1047 O
for 40 43 1048 1051 O
patients 44 52 1052 1060 O
who 53 56 1061 1064 O
have 57 61 1065 1069 O
a 62 63 1070 1071 O
positive 64 72 1072 1080 O
HBcAb 73 78 1081 1086 B-clinical_variable
test 79 83 1087 1091 O

The 0 3 1092 1095 O
HCV 4 7 1096 1099 B-clinical_variable
RNA 8 11 1100 1103 I-clinical_variable
test 12 16 1104 1108 I-clinical_variable
will 17 21 1109 1113 O
be 22 24 1114 1116 O
performed 25 34 1117 1126 O
only 35 39 1127 1131 O
for 40 43 1132 1135 O
patients 44 52 1136 1144 O
who 53 56 1145 1148 O
have 57 61 1149 1153 O
a 62 63 1154 1155 O
positive 64 72 1156 1164 O
HCV 73 76 1165 1168 B-clinical_variable
antibody 77 85 1169 1177 I-clinical_variable
test 86 90 1178 1182 I-clinical_variable

Treatment 0 9 1183 1192 O
with 10 14 1193 1197 O
investigational 15 30 1198 1213 B-treatment
therapy 31 38 1214 1221 I-treatment
within 39 45 1222 1228 O
30 46 48 1229 1231 B-upper_bound
days 49 53 1232 1236 I-upper_bound
prior 54 59 1237 1242 I-upper_bound
to 60 62 1243 1245 O
initiation 63 73 1246 1256 O
of 74 76 1257 1259 O
study 77 82 1260 1265 O
treatment 83 92 1266 1275 O

Uncontrolled 0 12 1276 1288 O
pleural 13 20 1289 1296 B-chronic_disease
effusion 21 29 1297 1305 I-chronic_disease
, 29 30 1305 1306 O
pericardial 31 42 1307 1318 B-chronic_disease
effusion 43 51 1319 1327 I-chronic_disease
, 51 52 1327 1328 O
or 53 55 1329 1331 O
ascites 56 63 1332 1339 B-chronic_disease

Uncontrolled 0 12 1340 1352 O
tumor 13 18 1353 1358 B-cancer
- 18 19 1358 1359 O
related 19 26 1359 1366 O
pain 27 31 1367 1371 O

Women 0 5 1372 1377 B-gender
of 6 8 1378 1380 O
child 9 14 1381 1386 O
bearing 15 22 1387 1394 O
potential 23 32 1395 1404 O
must 33 37 1405 1409 B-pregnancy
have 38 42 1410 1414 I-pregnancy
a 43 44 1415 1416 I-pregnancy
negative 45 53 1417 1425 I-pregnancy
serum 54 59 1426 1431 I-pregnancy
pregnancy 60 69 1432 1441 I-pregnancy
test 70 74 1442 1446 I-pregnancy
result 75 81 1447 1453 I-pregnancy
within 82 88 1454 1460 O
7 89 90 1461 1462 B-upper_bound
days 91 95 1463 1467 I-upper_bound
prior 96 101 1468 1473 O
to 102 104 1474 1476 O
initiation 105 115 1477 1487 O
of 116 118 1488 1490 O
study 119 124 1491 1496 O
drug 125 129 1497 1501 O

clinically 0 10 1502 1512 O
significant 11 22 1513 1524 O
( 23 24 1525 1526 O
symptomatic 24 35 1526 1537 O
) 35 36 1537 1538 O
hypercalcemia 37 50 1539 1552 B-chronic_disease

collected 0 9 1553 1562 O
â‰¤3 10 12 1563 1565 O
months 13 19 1566 1572 I-upper_bound
prior 20 25 1573 1578 I-upper_bound
to 26 28 1579 1581 O
randomization 29 42 1582 1595 O

interpretation 0 14 1596 1610 O
of 15 17 1611 1613 O
results 18 25 1614 1621 O
, 25 26 1621 1622 O
including 27 36 1623 1632 O
significant 37 48 1633 1644 O
liver 49 54 1645 1650 B-chronic_disease
disease 55 62 1651 1658 I-chronic_disease
, 62 63 1658 1659 O
cardiovascular 64 78 1660 1674 B-chronic_disease
disease 79 86 1675 1682 I-chronic_disease

positive 0 8 1683 1691 O
HBcAb 9 14 1692 1697 B-chronic_disease
test 15 19 1698 1702 O
followed 20 28 1703 1711 O
by 29 31 1712 1714 O
a 32 33 1715 1716 O
negative 34 42 1717 1725 O
hepatitis 43 52 1726 1735 B-chronic_disease
B 53 54 1736 1737 I-chronic_disease
virus 55 60 1738 1743 I-chronic_disease
( 61 62 1744 1745 I-chronic_disease
HBV 62 65 1745 1748 I-chronic_disease
) 65 66 1748 1749 I-chronic_disease
DNA 67 70 1750 1753 O
test 71 75 1754 1758 O
at 76 78 1759 1761 O
screening 79 88 1762 1771 O

previously 0 10 1772 1782 O
diagnosed 11 20 1783 1792 O
and 21 24 1793 1796 O
treated 25 32 1797 1804 O
spinal 33 39 1805 1811 B-chronic_disease
cord 40 44 1812 1816 I-chronic_disease
compression 45 56 1817 1828 I-chronic_disease
without 57 64 1829 1836 O
evidence 65 73 1837 1845 O
that 74 78 1846 1850 O
disease 79 86 1851 1858 O
has 87 90 1859 1862 O
been 91 95 1863 1867 O
clinically 96 106 1868 1878 O
stable 107 113 1879 1885 O
for 114 117 1886 1889 O
at 118 120 1890 1892 O
least 121 126 1893 1898 O
2 127 128 1899 1900 B-lower_bound
weeks 129 134 1901 1906 I-lower_bound
prior 135 140 1907 1912 I-lower_bound
to 141 143 1913 1915 O
randomization 144 157 1916 1929 O

progesterone 0 12 1930 1942 O
receptor 13 21 1943 1951 O
[ 22 23 1952 1953 O
PR 23 25 1953 1955 O
] 25 26 1955 1956 O
expression 27 37 1957 1967 O
) 37 38 1967 1968 O
, 38 39 1968 1969 O
not 40 43 1970 1973 O
amenable 44 52 1974 1982 O
to 53 55 1983 1985 O
surgical 56 64 1986 1994 B-treatment
therapy 65 72 1995 2002 I-treatment

uncontrolled 0 12 2003 2015 B-chronic_disease
hypercalcemia 13 26 2016 2029 I-chronic_disease

